Viewing Study NCT06265727


Ignite Creation Date: 2025-12-25 @ 5:19 AM
Ignite Modification Date: 2025-12-26 @ 4:26 AM
Study NCT ID: NCT06265727
Status: RECRUITING
Last Update Posted: 2025-11-04
First Post: 2024-02-08
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors
Sponsor: Corbus Pharmaceuticals Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module